Filgrastim biosimilar (Neiss Labs)

非格司亭生物类似药（Neiss Labs）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFilgrastim biosimilar (Neiss Labs)

Drug Alias Name重组人粒细胞刺激因子（Neiss Labs）rhG-CSF (Neiss Labs)非格司亭生物仿制药（Neiss Labs）Recombinant human granulocyte macrophage colony stimulating factor (Neiss Labs)Nisgras

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar

Mechanisms of ActionColony stimulating factor 3 receptor agonists

TargetsColony stimulating factor 3 receptor

Therapy Area/IndicationsNeutropenia

Global Approved IndicationsNeutropenia

Approved Indications in ChinaN/A

Original Approved Country/TerritoryIndia

Original Approved Date2012/08/01

Country/TerritoryIndia

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesNeiss Labs

China Registration ClassN/A

Develop Information

Active CompaniesNeiss Labs

Inactive CompaniesN/A

Active IndicationsNeutropenia

Inactive IndicationsN/A

Other Information

ATC CodeL03AA02